Literature DB >> 25968989

Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human Liver.

K S Burgess1,2, S Philips2, E A Benson2, Z Desta2, A Gaedigk3, R Gaedigk3, M W Segar4, Y Liu4,5, T C Skaar2.   

Abstract

Developmental changes in the liver can significantly impact drug disposition. Due to the emergence of microRNAs (miRNAs) as important regulators of drug disposition gene expression, we studied age-dependent changes in miRNA expression. Expression of 533 miRNAs was measured in 90 human liver tissues (fetal, pediatric [1-17 years], and adult [28-80 years]; n = 30 each). In all, 114 miRNAs were upregulated and 72 were downregulated from fetal to pediatric, and 2 and 3, respectively, from pediatric to adult. Among the developmentally changing miRNAs, 99 miRNA-mRNA interactions were predicted or experimentally validated (e.g., hsa-miR-125b-5p-CYP1A1; hsa-miR-34a-5p-HNF4A). In human liver samples (n = 10 each), analyzed by RNA-sequencing, significant negative correlations were observed between the expression of >1,000 miRNAs and mRNAs of drug disposition and regulatory genes. Our data suggest a mechanism for the marked changes in hepatic gene expression between the fetal and pediatric developmental periods, and support a role for these age-dependent miRNAs in regulating drug disposition.
© 2015 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25968989      PMCID: PMC4512918          DOI: 10.1002/cpt.145

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  50 in total

1.  Expression of CYP2D6 in developing human liver.

Authors:  J M Treluyer; E Jacqz-Aigrain; F Alvarez; T Cresteil
Journal:  Eur J Biochem       Date:  1991-12-05

Review 2.  Control of protein synthesis and mRNA degradation by microRNAs.

Authors:  Jidong Liu
Journal:  Curr Opin Cell Biol       Date:  2008-03-10       Impact factor: 8.382

3.  COPI transport complexes bind to specific RNAs in neuronal cells.

Authors:  Adrian G Todd; Hai Lin; Allison D Ebert; Yunlong Liu; Elliot J Androphy
Journal:  Hum Mol Genet       Date:  2012-11-21       Impact factor: 6.150

4.  The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.

Authors:  Liu Hong; Yu Han; Hongwei Zhang; Mengbin Li; Taiqian Gong; Li Sun; Kaichun Wu; Qingchuan Zhao; Daiming Fan
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

Review 5.  Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children.

Authors:  R N Hines
Journal:  Int J Pharm       Date:  2012-07-03       Impact factor: 5.875

6.  Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.

Authors:  D Lacroix; M Sonnier; A Moncion; G Cheron; T Cresteil
Journal:  Eur J Biochem       Date:  1997-07-15

7.  Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters.

Authors:  Miriam G Mooij; Ute I Schwarz; Barbara A E de Koning; J Steven Leeder; Roger Gaedigk; Janneke N Samsom; Edwin Spaans; Johannes B van Goudoever; Dick Tibboel; Richard B Kim; Saskia N de Wildt
Journal:  Drug Metab Dispos       Date:  2014-05-14       Impact factor: 3.922

8.  Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4.

Authors:  Shingo Takagi; Miki Nakajima; Takuya Mohri; Tsuyoshi Yokoi
Journal:  J Biol Chem       Date:  2008-02-11       Impact factor: 5.157

9.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

10.  Expression and significance of microRNA-183 in hepatocellular carcinoma.

Authors:  Zenghui Liang; Yingtang Gao; Wenxia Shi; Daokuan Zhai; Shilei Li; Li Jing; Hua Guo; Tong Liu; Yajie Wang; Zhi Du
Journal:  ScientificWorldJournal       Date:  2013-10-10
View more
  15 in total

Review 1.  Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes.

Authors:  Yeo-Jung Kwon; Sangyun Shin; Young-Jin Chun
Journal:  Arch Pharm Res       Date:  2021-01-23       Impact factor: 4.946

2.  Machine Learning Approach for Predicting Past Environmental Exposures From Molecular Profiling of Post-Exposure Human Serum Samples.

Authors:  Atif Khan; Thomas H Thatcher; Collynn F Woeller; Patricia J Sime; Richard P Phipps; Philip K Hopke; Mark J Utell; Pamela L Krahl; Timothy M Mallon; Juilee Thakar
Journal:  J Occup Environ Med       Date:  2019-12       Impact factor: 2.162

3.  miR-219a-5p Ameliorates Hepatic Ischemia/Reperfusion Injury via Impairing TP53BP2.

Authors:  Yu Xiao; Shouhua Zhang; Qiang Li; Zhiwen Liu; Wenli Mai; Wen Chen; Jun Lei; Huakun Hu
Journal:  Dig Dis Sci       Date:  2019-02-22       Impact factor: 3.199

4.  Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS Proteomics.

Authors:  B Prasad; A Gaedigk; M Vrana; R Gaedigk; J S Leeder; L Salphati; X Chu; G Xiao; Ceca Hop; R Evers; L Gan; J D Unadkat
Journal:  Clin Pharmacol Ther       Date:  2016-08-13       Impact factor: 6.875

Review 5.  PharmVar GeneFocus: CYP2C19.

Authors:  Mariana R Botton; Michelle Whirl-Carrillo; Andria L Del Tredici; Katrin Sangkuhl; Larisa H Cavallari; José A G Agúndez; Jorge Duconge; Ming Ta Michael Lee; Erica L Woodahl; Karla Claudio-Campos; Ann K Daly; Teri E Klein; Victoria M Pratt; Stuart A Scott; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2020-07-22       Impact factor: 6.875

Review 6.  Regulation of Human Cytochrome P4501A1 (hCYP1A1): A Plausible Target for Chemoprevention?

Authors:  Rebeca Santes-Palacios; Diego Ornelas-Ayala; Noel Cabañas; Ana Marroquín-Pérez; Alexis Hernández-Magaña; Sitlali Del Rosario Olguín-Reyes; Rafael Camacho-Carranza; Jesús Javier Espinosa-Aguirre
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

7.  Ontogeny-related pharmacogene changes in the pediatric liver transcriptome.

Authors:  Richard Meier; Chengpeng Bi; Roger Gaedigk; Daniel P Heruth; Shui Qing Ye; J Steven Leeder; Brooke L Fridley
Journal:  Pharmacogenet Genomics       Date:  2018-03       Impact factor: 2.089

Review 8.  Ten Years' Experience with the CYP2D6 Activity Score: A Perspective on Future Investigations to Improve Clinical Predictions for Precision Therapeutics.

Authors:  Andrea Gaedigk; Jean C Dinh; Hyunyoung Jeong; Bhagwat Prasad; J Steven Leeder
Journal:  J Pers Med       Date:  2018-04-17

9.  Hepatic Abundance and Activity of Androgen- and Drug-Metabolizing Enzyme UGT2B17 Are Associated with Genotype, Age, and Sex.

Authors:  Deepak Kumar Bhatt; Abdul Basit; Haeyoung Zhang; Andrea Gaedigk; Seung-Been Lee; Katrina G Claw; Aanchal Mehrotra; Amarjit Singh Chaudhry; Robin E Pearce; Roger Gaedigk; Ulrich Broeckel; Timothy A Thornton; Deborah A Nickerson; Erin G Schuetz; John K Amory; J Steven Leeder; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2018-03-30       Impact factor: 3.922

10.  Variants in the CYP2B6 3'UTR Alter In Vitro and In Vivo CYP2B6 Activity: Potential Role of MicroRNAs.

Authors:  Kimberly S Burgess; Joseph Ipe; Marelize Swart; Ingrid F Metzger; Jessica Lu; Brandon T Gufford; Nancy Thong; Zeruesenay Desta; Roger Gaedigk; Robin E Pearce; Andrea Gaedigk; Yunlong Liu; Todd C Skaar
Journal:  Clin Pharmacol Ther       Date:  2017-10-25       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.